Senior Advisor National Academy of Medicine
Laura L. Adams, Senior Advisor at the National Academy of Medicine (NAM), provides leadership for the NAM Digital Health and Evidence Mobilization portfolios of the Leadership Consortium. Her primary expertise is in digital health, biotech, and human-centered care. She serves on the boards of Boston-based T2 Biosystems and Translational Medicine Accelerator (TMA); and is a member of the Oversight Council for the Massachusetts Center for Health Information and Analysis. She is also an advisor for Inflammatix, a Burlingame, CA-based biotech company specializing in host immune response diagnostics. Previously, Laura was the founding President and CEO of the Rhode Island Quality Institute (RIQI), a statewide health information exchange.
